Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.375 USD | +0.27% | -0.66% | +37.36% |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.36% | 25.56M | |
+20.10% | 46.81B | |
-0.70% | 41.37B | |
+47.07% | 41.29B | |
-6.20% | 28.87B | |
+12.00% | 26.06B | |
-19.66% | 19.13B | |
+33.30% | 12.39B | |
+0.27% | 12.08B | |
+0.17% | 11.96B |
- Stock Market
- Equities
- BCLI Stock
- News Brainstorm Cell Therapeutics Inc.
- Maxim Group Adjusts Price Target on Brainstorm Cell Therapeutics to $10 From $5, Maintains Buy Rating